Core One Labs Announces Successful Proof of Concept and
VANCOUVER, British Columbia, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or...
Stay updated with breaking news from Psychedelic Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VANCOUVER, British Columbia, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or...
Having seen the life-changing benefits psilocybin therapy can bring, I hope UK patients will soon be able to access it safely and legally
Children with intractable epilepsy treated with whole-plant cannabis-based medical products experienced an 86% decrease in monthly seizures, a small case series reports.
UT Austin's Dell Medical School launched a center committed to researching the positive effects of psychedelic therapies on those suffering from PTSD, depression and anxiety.
AUSTIN, Texas – As part of renewed interest in using psychedelics to treat severe mental health conditions, especially for people who have not had success with more traditional treatments, researchers at Dell Medical School at The University of Texas at Austin have launched the Center for Psychedelic Research and Therapy – the first cen